| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 6 |
| 1 | DENOSUMAB | 2 |
| 2 | LENVATINIB | 2 |
| 3 | PACLITAXEL | 2 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 5 | PAZOPANIB | 2 |
| 6 | PAZOPANIB HYDROCHLORIDE | 2 |
| 7 | PEMBROLIZUMAB | 2 |
| 8 | PEMETREXED | 2 |
| 9 | PEMETREXED DISODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CERITINIB | 1 | 0.0004 |
| 1 | SORAFENIB | 6 | 0.0003 |
| 2 | FREMANEZUMAB-VFRM | 1 | 0.0001 |
| 3 | PAZOPANIB HYDROCHLORIDE | 2 | 0.0001 |
| 4 | LENVATINIB | 2 | 0.0001 |
| 5 | LITHIUM CARBONATE | 1 | 0.0001 |
| 6 | PEMETREXED DISODIUM | 2 | 0.0001 |
| 7 | PACLITAXEL | 2 | 0.0000 |
| 8 | PEMBROLIZUMAB | 2 | 0.0000 |
| 9 | EMPAGLIFLOZIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 1 | Kinase Inhibitor [EPC] | 7 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 3 | RANK Ligand Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 6 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |